Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Globalagliatin (LY2608204) has been used in trials studying the treatment of Diabetes Mellitus, Type 2.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 66.00 | |
5 mg | In stock | $ 158.00 | |
10 mg | In stock | $ 233.00 | |
25 mg | In stock | $ 393.00 | |
50 mg | In stock | $ 585.00 |
Description | Globalagliatin (LY2608204) has been used in trials studying the treatment of Diabetes Mellitus, Type 2. |
Targets&IC50 | GK:42 nM(EC50) |
In vitro | Under fasting and postprandial glucose conditions, LY2608204 demonstrated a dose-dependent reduction in blood glucose levels. Compared to the control group, the administration of a high dose of 30 mg/kg of the drug resulted in a maximum glucose-lowering effect of 42% on the glucose AUC. Interpolation analysis revealed that a 20% reduction in the glucose AUC occurred at an average LY2608204 concentration of 99 ng/mL (179 nM) in the plasma, equivalent to a dose of 6.9 mg/kg of LY2608204. The in vivo blood-brain barrier permeability of LY2608204 led to an average brain/plasma ratio of 0.17 and an average total brain level of 0.539 nmol/g, within 5 minutes. |
In vivo | LY2608204 acts on rat insulinoma INS1-E cells, stimulating glucose metabolism with an EC50 of 579 nM. It activates glucokinase, presenting an EC50 of 42 nM in the presence of 10 mM glucose, demonstrating a concentration-dependent activation at lower glucose concentrations. |
Synonyms | LY2608204 |
Molecular Weight | 559.81 |
Formula | C28H37N3O3S3 |
CAS No. | 1234703-40-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ethanol: 33 mg/mL (58.9 mM)
H2O: < 1 mg/mL (insoluble or slightly soluble)
DMSO: 103 mg/mL (184 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Globalagliatin 1234703-40-2 Metabolism Glucokinase Hexokinase IV Inhibitor LY 2608204 Hexokinase D LY-2608204 inhibit LY2608204 inhibitor